Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that 18.1% of health workers at Sanglah Hospital reported anxiety during the COVID-19 pandemic, with the highest levels in nurses and those in Non-COVID wards.

This study found that depression and anxiety are common in adults with systemic lupus erythematosus and are associated with increased disease activity and specific complications like hair loss and cardiac issues.

Hair loss can be linked to hormonal changes, and physical conditions like heart defects can cause depression.

This study found that the prevalence of alopecia areata in Japan increased from 2012 to 2019, with allergic diseases as common comorbidities and a need for more effective treatments, particularly for severe and pediatric cases.

This study found that finasteride is associated with significant depressive effects, including an increased risk of suicidality, which can persist beyond 20 months after stopping the medication, even without prior sexual dysfunction or psychiatric history.

In this study, hair loss was found to be associated with increased depressive symptoms among MZ generation individuals, particularly affecting women, smokers, and older age groups, suggesting a potential link between hair health and mental well-being.

This review highlights that alopecia areata is influenced by genetic, autoimmune, and environmental factors, with emerging treatments like JAK-2 inhibitors showing promise for severe cases.

Former finasteride users showed higher rates of depression and suicidal thoughts compared to those who never used it.

In this study, alopecia areata and vitiligo patients had significantly lower serum BDNF and vitamin D levels, which were inversely associated with depression and quality of life, suggesting a potential combined role in the development of depression.

This study found that infertile women with polycystic ovary syndrome in Ardabil had a significantly higher rate of depression compared to those without the condition, highlighting the need for attention to the mental health aspects of PCOS.

This study highlights the significant psychological impact of alopecia areata, emphasizing the reciprocal relationship between the disorder and psychiatric issues, and underscores the importance of identifying patients needing additional psychological support, especially women, young individuals, and those with severe alopecia or previous psychiatric history.

In this study, depression and anxiety were prevalent in Thai women with PCOS, with hirsutism being a key factor linked to these mental health issues, suggesting a need for targeted screening.

This case report describes a 10-year multidisciplinary treatment of a transgender woman in Slovenia, reporting a successful medical and social transition with stable emotional health, abstinence from alcohol, and no regrets following her transition.

This study found that obesity, insulin resistance, and hyperandrogenism increase the risk of depression and food cravings in women with PCOS, exacerbating obesity and metabolic syndrome.

JAK inhibitors help regrow eyebrow and eyelash hair and improve anxiety and depression in some alopecia areata patients.

In this prospective study, ritlecitinib effectively reduced hair loss in patients with severe alopecia areata, with 43.3% of participants achieving a 20 or lower SALT score by week 24, and showed a good midterm safety profile.

The researchers reported that baricitinib treatment for at least 52 weeks reduced severe alopecia areata severity and improved psychological well-being and quality of life in study participants.

This study found that non-small-cell lung cancer patients experienced less adverse events with third-generation EGFR-TKIs compared to first and second generations, although fear of cancer progression, anxiety, and depression were still prevalent.

This study observed that alopecia areata patients experience significant psychosocial issues, with a high prevalence of anxiety, depression, and impaired quality of life across symptoms, functioning, and emotions.

This study found that androgenetic alopecia in men is associated with significant psychological distress and moderate depression, suggesting a possible link between raised dihydrotestosterone levels and mental health issues.

This study in the United Arab Emirates found that alopecia areata significantly impacts patient quality of life and healthcare resource utilization, particularly among those with higher scalp hair loss.

This study found that patients with androgenetic alopecia and alopecia areata experienced a significant impact on quality of life, with moderate levels of anxiety and depression, and no significant difference in psychiatric comorbidities between the groups.

In this study, patients with lichen planopilaris and frontal fibrosing alopecia reported a substantial impairment in quality of life and experienced high levels of stress, often considering stress a cause of their condition.

This review examines the psychological effects of chronic hair diseases and reports no new findings, highlighting the impact on self-confidence, coping skills, and associated psychiatric conditions.

This study concluded that psychological well-being and self-image among Filipino males with androgenetic alopecia may be influenced by age, education level, and disease severity.

This review highlights the significant negative impact of alopecia areata on quality of life, mental health, and work, calling for individualized approaches and effective treatments to mitigate these effects.

In this study conducted in Trinidad, higher income was associated with reduced risk of menstrual dysfunction and combined hyperandrogenism/menstrual dysfunction, impacting mental and overall health in women with probable PCOS.

This study found that women with PCOS have a significant risk of mental health disorders, including depression and anxiety, but results varied due to methodological differences, and ethnic disparities were not well-examined.

This study found that females with chronic alopecia, including both alopecia areata and androgenetic alopecia, experienced higher levels of depression, anxiety, and alexithymia than healthy controls.

This review discusses the range of long-term complications, including mucocutaneous, ocular, and psychological sequelae, for survivors of Stevens–Johnson syndrome and toxic epidermal necrolysis, but reports no new clinical results.